Most contemporary accounts of psychopathology acknowledge the importance of both biological and environmental influences on behavior. In developmental psychopathology, multiple etiological mechanisms for psychiatric disturbance are well recognized, including those operating at genetic, neurobiological, and environmental levels of analysis. However, neuroscientific principles are rarely considered in current approaches to prevention or intervention. In this article, we explain why a deeper understanding of the genetic and neural substrates of behavior is essential for the next generation of preventive interventions, and we outline 10 specific reasons why considering biological processes can improve treatment efficacy. Among these, we discuss (a) the role of biomarkers and endophenotypes in identifying those most in need of prevention; (b) implications for treatment of genetic and neural mechanisms of homotypic comorbidity, heterotypic comorbidity, and heterotypic continuity; (c) ways in which biological vulnerabilities moderate the effects of environmental experience; (d) situations in which Biology Â Environment interactions account for more variance in key outcomes than main effects; and (e) sensitivity of neural systems, via epigenesis, programming, and neural plasticity, to environmental moderation across the life span. For each of the 10 reasons outlined we present an example from current literature and discuss critical implications for prevention.
Throughout much of the 20th century, psychology was portrayed as a fledgling discipline compared with other physical sciences. Less than five decades ago, the eminent philosopher Thomas Kuhn (1962) described psychology as preparadigmatic, with no established network of widely agreed upon principles or facts. Psychologists of the time were engaged in controversy over the proper approach to understanding human behavior, from unobservable unconscious motives at one end of the continuum to decontextualized operant behaviors at the other. Although the operant approach yielded some degree of prediction and control over behavior, as demonstrated by Hull's (1943) elaboration of Thorndike's (1911) law of effect, philosophers of science often compared psychology to physics and chemistry, which are replete with largely indisputable laws and axioms. These laws provide a level of precision in predicting future events that psychology will likely never achieve (see Beauchaine, Gatzke-Kopp, & Mead, 2007; Beauchaine, Lenzenweger, & Waller, 2008) .
Direct comparisons between psychology and the hard sciences are now recognized as simplistic, given the overwhelming number of causal influences affecting human behavior. Yet criticisms of psychology as a soft science and disagreement over the proper level of analysis for studying human behavior remain. This is particularly evi-dent in clinical psychology, where debates often emerge over appropriate foci of scientific inquiry. Many have argued that clinical psychology should be first and foremost an applied discipline that develops cognitive, behavioral, and social interventions to prevent and treat maladaptive behavior (e.g., Davison, 1998) . Some have even argued that focusing on genetic and neurobiological influences on behavior diverts our attention away from social and familial processes that promote psychopathology (e.g., Albee & Joffe, 2004) . In contrast, others have advocated for a clinical science that examines genetic and neural mechanisms of vulnerability, assuming that understanding such mechanisms will improve our ability to reduce psychiatric morbidity and mortality (e.g., Beauchaine & Marsh, 2006; Cicchetti & Dawson, 2002; Davidson, Pizzagalli, Nitschke, & Putnam, 2002; Fishbein, 2000; Nelson et al., 2002) .
Internecine squabbles over the identity of clinical psychology tend to emerge whenever the discipline reacts, often slowly, to paradigm shifts occurring in other areas of psychology. For example, behavioral principles offered by learning theorists including Hull (1943) and Skinner (1938) led to a gradual shift in clinical thinking that culminated in the 1970s, when the power of operant principles in shaping and changing human behavior was acknowledged. As a result, behaviorism supplanted psychoanalysis as the dominant clinical paradigm of the time.
However, as most readers are undoubtedly aware, the heyday of behaviorism was short lived. During the late 1970s and 1980s, a cognitive revolution swept psychology, shifting emphasis away from strict stimulus-response models of learning toward social-cognitive motivations for behavior. As a result, clinical scientists including Beck (e.g., Beck, Rush, Shaw, & Emery, 1979) , Ellis (e.g., 1981) , and Linehan (1993) formulated cognitive behavioral therapies for a wide range of psychiatric disorders. This change was less protracted than past paradigm shifts because cognitive models were fully compatible with the behavioral principles that preceded them. The two approaches could therefore be combined into an inclusive set of therapeutic methods. The cognitive behavioral approach that resulted remains the dominant paradigm in clinical psychology today.
By the late 1990s, yet another paradigm shift had permeated most of psychology. Basic scientists had begun using modern neuroscience techniques to probe the genetic and neural correlates of behavior. With sophisticated methods such as molecular genetics, electroencephalography (EEG), functional magnetic resonance imaging (fMRI), and positron emission tomography (PET), scientists were poised to tackle some of the most longstanding questions about learning and behavior. How do genes affect personality? Where are memories stored? How does the human brain learn? What are the brain bases of language? What neural processes give rise to emotions? How does psychopathology develop?
Despite the enormous promise of these methods, many early studies using molecular genetics and imaging technologies were crude because scientists did not yet appreciate the complexity of the systems they were observing. Naive searches for "the gene" controlling complex disorders such as depression and schizophrenia were not uncommon. Similarly, claims were made that the brain loci of mood disorders, anxiety, and emotion had been found. Although such simplistic assertions still appear in the popular press, geneticists and neuroscientists are now well aware that (a) genes do not control behaviors directly, (b) almost all behavioral traits emerge from complex interactions between multiple genes and environments, and (c) the brain bases of both personality and psychopathology are distributed across complex neural networks and are not caused by single loci, except in the most extreme cases of focal lesions. Thus, modern neuroscience is much more sophisticated than its earlier instantiations (Cicchetti & Posner, 2005; Davidson, 2003) .
Biology, Neuroscience, and Prevention
The tendency of clinical psychology to respond slowly to paradigm shifts that are embraced by other areas of psychological science is clearly evident in neuroscience. Most clinical psychology programs offer minimal training in the brain bases of behavior, if they offer any such training at all, and clinical neuroscience articles are still a rarity in the Journal of Abnormal Psychology and the Journal of Consulting and Clinical Psychology, flagship journals of the profession. Perhaps of more importance, neuroscientific principles are almost completely absent from current theoretical formulations of prevention and intervention. Although exceptions to this generalization can be found in research on autism spectrum disorders (e.g., Dawson, this issue; Dawson et al., 2002) , posttraumatic stress disorder (PTSD; e.g., Bryant, 2006) , and borderline pathology (e.g., Schnell & Herpertz, 2007) , clinical psychology as a whole has not embraced neuroscience, despite extraordinary advances in our understanding of the brain bases of motivation, emotion, and self-control. Yet dysfunction in one or more of these aspects of behavior is observed in all forms of psychopathology. Even though neuroscientific findings have resulted in rich theoretical models of major psychiatric disorders (Berridge & Robinson, 2003; Davidson et al., 2002; Gatzke-Kopp & Beauchaine, 2007a; Sagvolden, Johansen, Aase, & Russell, 2005) , they are usually not considered in clinical prevention or intervention programs.
To be fair, the behavioral and cognitive paradigm shifts described above yielded principles that were much easier to implement in applied clinical settings. Nevertheless, the current underappreciation of biological processes in prevention and intervention research is striking. Of the few studies that have included such variables, some have explored the effects of treatment on the functioning of biological systems implicated in stress reactivity and self-regulation (e.g., Fisher, Gunnar, Chamberlain, & Reid, 2000) , and others have examined the moderating effects of biological variables on treatment outcome. For example, Fishbein, Hyde, Coe, and Paschall (2004) examined the responses of adolescents to a preventive intervention for drug abuse. Skin conductance was included as one measure of emotional functioning, and differentiated in part between responders and nonresponders. Similarly, Raine, Mellingen, Liu, Venables, and Mednick (2003) explored the potential moderating effect of children's autonomic functioning on schizotypy and antisocial behavior in adolescence and adulthood following a generic preschool prevention program. Although they did not find evidence for moderation, the preschool prevention program did yield significant increases in psychophysiological orienting and arousal (as measured by skin conductance and EEG) at age 11, perhaps suggesting enhanced information processing abilities (Raine et al., 2001) . Such use of biological markers in longitudinal outcome research represents a first step toward a more integrated prevention science.
In addition to exploring moderators of outcome, some researchers have included biological variables as indicators of vulnerability to psychopathology. Following arguments that etiological heterogeneity among high-risk groups should predict differential treatment responses (e.g., Beauchaine & Marsh, 2006; Cicchetti & Rogosch, 2002) , researchers have sought to identify particularly vulnerable individuals based on specific genetic and neurobiological markers (see, e.g., Gottesman & Gould, 2003) . Bryant (2006) , for example, explored heart rate as a marker of risk for PTSD following trauma. After reviewing a number of studies, he concluded that heart rate, in combination with diagnostic status shortly after the trauma (whether or not participants met criteria for acute stress disorder), predicted the emergence of PTSD. In molecular genetics research, Young, Lawford, Nutting, and Noble (2004) conducted a series of meta-analyses examining the role of the dopamine receptor D2 (DRD2) A 1 allele, concluding that it "shows promise as a marker of substance use, and of severe substance misuseinparticular"(p.1288).Suchfindingshighlight the potential role of genetic and biological characteristics in identifying individuals who are at increased risk of adverse outcomes, and who are therefore most in need of prevention.
Despite such examples, inclusion of biological processes in prevention research lags well behind recent advances in our understanding of the neurobiological substrates of psychopathology. This may result in part from anachronistic notions about the respective roles of neurobiological and environmental influences on behavior. Indeed, decisions regarding whether and how to incorporate biological variables into prevention research often revolve around the degree to which psychological outcomes are conceptualized as stemming from biological vulnerabilities versus social and environment risk factors.
A recent special issue of the Journal of Primary Prevention explored the question of whether those at risk for psychopathology would be best served by a prevention science that emphasizes biological or psychosocial factors. Joffe (2004) and others argued that emphasizing biological vulnerabilities frames psychological problems as medical illnesses, a comparison that many find unsatisfying, for a number of reasons. For example, Albee and Joffe (2004) assert that there is insufficient evidence of reliable brain abnormalities in individuals with most psychiatric disorders. With the exception of conditions such as Alzheimer disease, they argue that "the evidence for mental disorders being caused by biochemical or structural abnormalities of the brain is generally sparse and inconsistent at best" (p. 425). Similarly, Boyle (2004) stated that there is "no evidence of a causal relationship between schizophrenia diagnoses and any genetic or biochemical event or process" (p. 450).
In our view, such statements (a) oversimplify complex relations between biological vulnerabilities and environmental risk factors in producing psychopathology; (b) place too much emphasis on the main effects of biology and environment, when research in developmental psychopathology indicates that interaction effects often account for more variance in adverse outcomes (see below); and (c) are in some cases clearly inaccurate. For example, a large volume of research indicates that schizophrenia is about 80% heritable (see Rapoport, Addington, & Frangou, 2005) , and is caused by genetic and neurobiological processes that give rise to compromises in both the structure and function of the brain (see, e.g., Gottesman & Gould, 2003; Reichenberg & Harvey, 2007) . Although debate exists over the precise mechanisms that underlie these structural and functional compromises (e.g., Craddock, O'Donovan, & Owen, 2007; Gottesman & Gould, 2003; McClellan, Susser, & King, 2007) , denying that schizophrenia has biological bases can only result from ignoring overwhelming evidence to the contrary, as discussed in later sections.
Arguments against psychopathology as medical illness are also based on the claim that psychiatric disorders do not represent distinct diagnostic entities, but instead reflect points along symptom continua. As noted by Albee and Joffe (2004) and others (see Beauchaine, 2003; Lilienfeld & Marino, 1999) , decisions regarding where along such continua normative functioning ends and psychopathology begins are often based more heavily on value judgments than on knowledge about underlying biological mechanisms, clear and specific biobehavioral links, or established causal factors. However, this argument ignores the fact that many life-threatening medical conditions, such as hypertension and type II diabetes, are also expressed along symptom continua and have multiple etiological influences, both biological and environmental. Nevertheless, preventive interventions targeting those at highest biological risk for these medical conditions have saved uncounted numbers of lives, and can delay the onset of functional impairment by decades.
Related arguments against incorporating biological processes into prevention research also stem from beliefs that doing so wrongly reinforces a medical or "defect" model of psychopathology in which "all mental illnesses are caused by biological, biochemical, and/or other organic defects" (Albee & Joffe, 2004, p. 424 ). Yet contemporary models of psychopathology acknowledge the importance of both neurobiological and environmental influences on behavior. In developmental psychopathology, multiple etiologies for many psychiatric conditions are well recognized. Different individuals presenting with what appears to be a single psychiatric disorder can arrive at similar levels of functioning via diverse equifinal outcomes, some of which include strong biological vulnerability and less environmental risk, and others of which include less biological vulnerability and strong environmental risk (see, e.g., Beauchaine & Marsh, 2006; Cicchetti & Rogosch, 1996) . This is why it is critically important to measure both classes of variables and their interactions in clinical research.
Opponents of biological approaches to prevention and intervention also argue that by emphasizing genetic and neurobiological processes, we divert attention and resources away from important psychosocial causes of maladjustment, such as stress, poverty, and family interactions: "If all 'mental illnesses' result from pathologies in the brain . . . then efforts at prevention need pay little attention to the social environment in which the affected person lives and has developed" (Albee & Joffe, 2004, p. 434) . Some authors have suggested that clinical research and prevention programs should therefore focus exclusively on environmental risks, and that individuals with psychiatric disorders are using normal mechanisms to adjust to aberrant environmental inputs (Silvestri & Joffe, 2004) .
Other researchers have offered compelling reasons to include genetic and other biological processes in prevention research (e.g., Agrawal & Hirsch, 2004; Ames & McBride, 2006; Fishbein, 2000; Gottlieb & Willoughby, 2006; Gunnar & Fisher, 2006) . Perhaps most fundamentally, assessing biological variables advances our understanding of the etiological complexities of developing psychopathology, eventually leading to targeted interventions (Beauchaine & Marsh, 2006) . For example,althoughearlyconceptualizationsofschizophrenia posited single genetic loci (e.g., Meehl, 1962) , extensive research on the biological substrates of the disorder has revealed complex polygenic influences that interact with environmental risk to potentiate psychiatric morbidity (e.g., Gottesman & Gould, 2003) . As we outline in detail below, by specifying behavioral and biological endophenotypes that mark this genetic risk (e.g., Erlenmeyer-Kimling, Golden, & Cornblatt, 1989; Tyrka et al., 1995) , prevention researchers can now identify children and adolescents who are particularly vulnerable to developing schizophrenia, and implement preventive interventions that reduce the likelihood of future psychosis and improve long-term prognosis (see, e.g., Beauchaine & Marsh, 2006; McGorry et al., 2002) .
Similar interactive complexities have been identified at neurobiological levels of analysis. For example, psychophysiological research indicates that basic motivational and emotion regulatory mechanisms interact with one another to potentiate disorders of impulse control including attentiondeficit/hyperactivity disorder (ADHD), conduct disorder (CD), and intentional self-injury (Beauchaine, Katkin, Strassberg, & Snarr, 2001; Crowell, Beauchaine, McCauley, Smith, Vasilev, & Stevens, 2008; Gatzke-Kopp et al., 2007; Shannon, Beauchaine, Brenner, Neuhaus, & GatzkeKopp, 2007) . These biobehavioral vulnerabilities also interact with environmental risk factors to predict adverse outcomes Patterson, DeGarmo, & Knutson, 2000; Snyder, Schrepferman, & St. Peter, 1997) .
Finally, biologically informed research has already yielded tremendous advances in the prevention of some psychiatric disorders. Once thought to be solely the result of inadequate parenting (Klinger, Dawson, & Renner, 2003) , autism spectrum disorders are now recognized to stem from multiple genes (Schellenberg et al., 2006 ), yet early environmental interventions for those exhibiting endophenotypic markers of risk offer profound protective effects for many children with the disorder (Dawson, this issue; Dawson & Zanolli, 2003) .
Developmental Psychopathology and Prevention
Several tenets of the developmental psychopathology perspective are relevant to this discussion. Developmental psychopathologists acknowledge that both biological vulnerabilities and environmental risk factors contribute to adjustment and maladjustment, and that apparent maladaptation can often be understood as adaptation to noxious environmental contexts (e.g., Cicchetti, 2006) . This framework emphasizes interactions between individuals and their environments (Rutter & Sroufe, 2000; Sroufe & Rutter, 1984) , which occur at multiple levels of analysis, including genetic, epigenetic, neurobiological, familial, and social (Cicchetti, 2007; Cicchetti & Dawson, 2002; Moffitt, Caspi, & Rutter, 2006) . This is a transactional approach, as influence flows across all levels of analysis. Family environments, social conditions, and psychological processes all affect biological processes, and biological functioning and predispositions influence the ways in which an individual selects and shapes the environment (see Rutter, 2002 Rutter, , 2007 .
In acknowledging these interactive processes, developmental psychopathologists must also recognize the probabilistic nature of predicting adverse outcomes. Psychopathology results from unique combinations of environmental risk factors, genetic vulnerabilities, and biological processes specific to each individual. The same set of vulnerabilities may be associated with various outcomes depending on a multitude of intervening risk factors (multifinality), and individuals can arrive at the same outcome via different combinations of vulnerability and risk (equifinality; Cicchetti & Rogosch, 1996) . Multifinality is demonstrated in studies of maternal depression, where children are at increased risk of both depression and CD . Thus, the same risk factor operates differently for different children. Equifinality is also observed in the development of CD. Adolescents who meet criteria form a heterogeneous group, often varying in both developmental history and symptom presentation (Hinshaw & Lee, 2003; Moffitt & Caspi, 2001 ).
Exploring biological processes is fundamental to the developmental psychopathology framework. For the past two decades, developmental psychopathologists have emphasized that including biological variables in studies of psychopathology will improve our understanding of risk factors and predictors of later functioning, both independently and in combination with various environmental and psychosocial characteristics. The very concept of prevention implies inferred risk to an individual, which may lead to a harmful outcome, either directly or through another potentiating risk factor (e.g., early-onset CD potentiates risk for substance use disorders [SUDs] ).
In targeted prevention programs, individuals are selected for treatment based on exposure to one or more risk factors that are known to promote psychopathology. In the traditional approach to prevention research, these risk exposures are usually environmental (e.g., family history, neighborhood), although individual characteristics are sometimes targeted (e.g., IQ, age, gender). Yet, biological vulnerabilities may be equally important. Recent research indicates quite clearly that an individual's genetic constitution may confer risk directly or through interactions with adverse environments (e.g., Caspi et al., 2002; Cicchetti, 2007; Jaffee et al., 2005) .
It should also be noted, however, that biological markers of vulnerability are rarely deterministic. As we discuss in more detail, neurobiological systems that are implicated in vulnerability to psychopathology are often malleable (e.g., Raine et al., 2001) , especially early in life, which is sometimes overlooked by opponents of biological research. Thus, identification of biologically based vulnerabilities may provide fruitful targets for both prevention and intervention. Similarly, biological variables that moderate the relationship between various risk factors and adverse outcomes should be targets of treatment when possible.
From this discussion it should be clear that we strongly favor an approach to prevention and intervention that includes consideration and/or assessment of biological vulnerabilities, environmental risk factors, and their interactions. We state at the outset that we are not suggesting that biological variables be measured in all prevention and intervention trials, although there are many cases in which measuring appropriate biological systems will be fruitful. Rather, we suggest that the efficacy and/or efficiency of many treatment programs will be improved by considering biological mechanisms of psychopathology. In the following sections we provide 10 compelling reasons for such an inclusive approach, most of which are supported by one or more examples from existing research. Readers should note that any one of these items could be addressed in a full-length article, so our descriptions are necessarily limited in scope. Although several of these items are interrelated, points of emphasis vary enough to warrant separate sections for each.
Ten Good Reasons to Consider Biological Variables in Prevention and Intervention Research
Markers of biological vulnerability can identify those at greatest risk for psychopathology Over four decades ago, Dawes and Meehl (1966) suggested that premorbid identification of individuals at risk for psychopathology should be a high priority because it is a necessary antecedent to prevention. Findings discussed briefly above suggest that by measuring relevant biological markers and/or endophenotypes (for discussion of the distinction between biomarkers and endophenotypes, see Gould & Gottesman, 2006) , we may be able to isolate those who are at risk for future psychopathology, and develop prevention and intervention programs targeting these individuals. Blanket prevention programs that enroll children at all levels of risk are often inefficient, and can result in underestimates of intervention effects because significant behavior change is not expected among children who are not at risk for psychopathology.
Research addressing biological risk among the offspring of a parent with schizophrenia provides a particularly compelling example of using endophenotypes to identify vulnerable children premorbidly (Beauchaine & Marsh, 2006) . By performing taxometric analyses on measures of sustained visual attention, neuromotor performance, and intelligence, Erlenmeyer-Kimling et al. (1989) identified a discrete group of 7-to 12-year-old children of a parent with schizophrenia who were at especially high risk of developing the disorder. Although the base rate of genetic risk for schizophrenia (schizotypy) is 5% in the general population (Blanchard, Gangestad, Brown, & Horan, 2000; Golden & Meehl, 1979; Korfine & Lenzenweger, 1995; Lenzenweger, 1999; Lenzenweger & Korfine, 1992) , 47% of children with an affected parent were members of the identified schizotypy taxon, compared with the expected 4% of controls. Of more importance, 43% of the schizotypy group were either hospitalized or had received significant treatment by age 22-29. Similar results were reported by Tyrka et al. (1995) , who used behavioral data derived from school reports and psychiatric interviews to identify a discrete schizotypy group of 10-to 19-year-old offspring of mothers with schizophrenia. The 48% taxon base rate was nearly identical to that reported by ErlenmeyerKimling et al. Moreover, 40% of taxon group members were diagnosed with a schizophrenia spectrum disorder 24-27 years later. Thus, taxometric analyses of selected behavioral and endophenotypic markers of genetic risk can identify particularly vulnerable individuals prospectively.
Implications for prevention and intervention.
The importance of these findings for prevention is difficult to overstate. Blanket prevention programs for all children of parents with schizophrenia are inefficient because only 10-15% eventually develop a schizophrenia spectrum disorder (see Cornblatt, Obuchowski, Roberts, Pollack, & Erlenmeyer-Kimling, 1999 ). Yet in the two studies cited above, taxon group members were at nearly 50% risk. This level of vulnerability renders schizophrenia (and other) prevention programs much more pragmatic (Cornblatt, 2001) . Furthermore, advances in identification of endophenotypes that mark schizophrenia liability, including impaired attention, saccadic intrusions in smooth pursuit eye tracking, and spatial working memory deficits (Cornblatt & Malhotra, 2001; Glahn et al., 2003; Lenzenweger, McLachlan, & Rubin, 2007; Reichenberg & Harvey, 2007; Ross, 2003) , should facilitate premorbid identification at even younger ages. The earlier environmentally focused interventions are implemented, the more likely they are to prevent the onset of schizophrenia because accumulated environmental risk across development potentiates genetic vulnerability (see Goldsmith, Gottesman, & Lemery, 1997; Gottesman & Gould, 2003; Rutter et al., 1997) .
Although these findings have not been incorporated into prevention trials to date, considerable advances in the prevention of schizophrenia have been reported. Prevention programs that include both cognitive behavioral and pharmacological components appear to be especially promising for those at risk for schizophrenia. McGorry et al. (2002) demonstrated that cognitive behavioral therapy (CBT), combined with a low dose of Risperidone (1-2 mg/day) substantially reduced the onset of first-episode psychosis in high-risk patients who had a positive family history and incipient but subthreshold symptoms. Those who took a low dose of Risperidone and participated in CBT were 95% psychosis-free 3 years later, compared with only 40% of patients who did not adhere to the Risperidone treatment and 30% of patients who received a typical needs-based intervention. These findings are important because early treatment of psychosis is associated with improved long-term prognosis (see Cornblatt, Lencz, & Kane, 2001) . Similar effects of early intervention on delaying the age of onset for bipolar disorder have recently been described (Chang, Gallelli, & Howe, 2007; Miklowitz, 2007) .
Heritable effects on behavior increase across the life span
Behavioral genetics studies have demonstrated increasing heritability coefficients across the life span for a wide range of psychiatric disorders (Lemery & Doelger, 2005) . This generalization applies to almost all forms of psychopathology for which heritability has been assessed at different points in development, which (a) bears directly on the often repeated claim that environmental contexts are the primary "cause" of psychopathology (e.g., Albee & Joffe, 2004) ; (b) has received almost no attention in the clinical psychology and developmental psychopathology literature; (c) has direct implications for interpretations of the relative contributions of biological vulnerability and environmental risk for psychiatric disturbance; and (d) affects the long-term efficacy of prevention programs, which by nature target early environments to effect behavioral change.
A number of examples of rising heritability across development are noteworthy. Twin studies of depression indicate that heritability contributes minimally to symptom expression in childhood (Lemery & Doelger, 2005; Rice, Harold, & Thapar, 2002) yet increases during adolescence (Scourfield et al., 2003) . By adulthood, most behavioral genetics studies yield large heritability coefficients for major depression, with nonsignificant environmental effects (Sullivan, Neale, & Kendler, 2000) .
Heritability coefficients for eating disorders among females and antisocial behavior among males also increase across the life span (Hicks et al., 2007; Klump, McGue, & Iacono, 2000; Lyons et al., 1995) . Furthermore, although environmental factors contribute strongly to the initiation of smoking and drinking, behavioral genetics studies indicate that both smoking maintenance and heavy drinking are accounted for primarily by heritable effects (e.g., Boomsma, Koopsman, Van Doormen, & Orlebeke, 1994; Koopsman, Slutzke, Heath, Neale, & Boomsma, 1999; Koopsman, van Doornen, & Boomsma, 1997; McGue, Iacono, Legrand, & Elkins, 2001; Viken, Kaprio, Koskenvuo, & Rose, 1999) .
To explain such findings, researchers have speculated that the nature of psychiatric disorders may be qualitatively different in children than in adolescents and adults (e.g., Klein, Torpey, Bufferd, & Dyson, 2008) , different genetic factors operate in childhood versus adolescence (Jacobson, Prescott, & Kendler, 2000) , and observed differences in heritability may reflect diverse pathways to psychopathology (e.g., Silberg, Silberg, Rutter, Neale, & Eaves, 2001) . Although these and related mechanisms may be at play, developmental increases in heritability coefficients are a mathematical necessity in twin and adoption studies given individual differences in age of onset, even when the etiologies of the psychiatric disorder being assessed are quite similar across members of a population. This is illustrated in Figure 1 , which depicts 10 hypothetical twin pairs, all of whom are at high genetic risk for schizophrenia. Because of differences in age of onset, concordance rates rise from childhood through adulthood. Because age of onset is dispersed across many years for most psychiatric disorders as a result of nonshared environmental effects, unmeasured stochastic effects, and allostatic load, heritability coefficients must increase across the life span. 1 The only exceptions to this rule are disorders with very early and relatively invariant ages of onset, such as autism.
Implications for prevention and intervention. There are several potential implications of such developmental increases in heritability for prevention. Although targeted preventions can delay and in some cases offset the emergence of highly heritable psychiatric conditions such as schizophrenia (McGorry et al., 2002) , life span increases in heritability suggest that the effectiveness of many prevention programs should erode over time. This is consistent with outcome data from a wide range of prevention and intervention studies. Although significant resources have been invested in both primary and targeted prevention for a range of disorders (see, e.g., Evans et al., 2005) , the long-term efficacy of many of these programs is limited at best (e.g., Fingeret, Warren, Cepeda-Benito, & Gleaves, 2006; Foxcroft, Ireland, Lister-Sharp, Lowe, & Breen, 2003; Lynam et al., 1999) . Worse yet, iatrogenic effects have been demonstrated for many prevention and early intervention programs that aggregate those who are at risk for psychopathology (see Dishion, McCord, & Poulin, 1999; Lilienfeld, 2007; Petrosino, Turpin-Petrosino, & Buehler, 2003; Rhule, 2005) . One possible explanation for these negative effects is that too little attention has been paid to the power of such programs to potentiate genetic risk via exposure 1. This statement begs an obvious question: if nonshared environmental effects and allostatic load affect age of onset for those who are genetically predisposed to psychopathology, should not it be the interaction between heritable vulnerability (G) and environmental risk (E) that rises across the life span, rather than the main effect of heritability? In brief, the answer to this question is often "yes." However, HeritabilityÂEnvironment (GÂE) interactions cannot be disentangled from pure heritability effects in behavioral genetics research unless the specific environmental variable that interacts with heritability is measured, which is often not the case. When the effects of environmental are not measured directly, G Â E interactions are subsumed within the heritability effect (see, e.g., Rutter, 2007) . Although full discussion of this issue is beyond the scope of this article, unmeasured effects of environment can result in inflated estimates of heritability.
to the high-risk behaviors of other enrollees. For example, children who are at high genetic risk for delinquency should not be aggregated with delinquent peers, as such exposure constitutes a potentiating (high risk) environment. When we study only child and adolescent samples, as many prevention researchers do, it is easy to overlook the powerful role that heritability plays in the expression of adult psychopathology. Because heritability coefficients for childhood disorders are low, prevention researchers may conclude erroneously that environmental risk "causes" psychopathology, and that biological vulnerabilities are unimportant (e.g., Albee & Joffe, 2004; Boyle, 2004; Joffe, 2004) . Even among prevention researchers who are aware of behavioral genetics data on child and adolescent psychopathology, the importance of heritability may be underestimated unless a life span approach is adopted. As the above discussion illustrates, the long-term costs of underestimating heritability may be high.
Prevention researchers should expect erosion of treatment efficacy over time, and design Figure 1 . A hypothetical distribution of individual differences in age of onset for schizophrenia across 10 twin pairs. Solid bars indicate age of onset for each individual. Concordance is determined by the proportion of the 10 twin pairs who are both afflicted. Because individual differences in age of onset are observed for almost all forms of psychopathology, concordance rates necessarily increase across the life span. Note that the final concordance rate of .80 indicates a highly heritable trait. Although dichotomous outcomes are used for simplicity of presentation, the same argument applies to continuously assessed traits.
programs to mitigate such effects through empirically supported adjunctive treatments, including available medication management that targets neurobiological sequelae of genetic risk (see, e.g., Jensen, Hinshaw, Swanson et al., 2001; McGorry et al., 2001 ) and intensive and regular follow-ups ("booster sessions") that prevent behavioral drift (e.g., Lochman, 1992) .
In addition, those who are at high genetic risk for psychopathology, as determined by family history interviews, genetic assays, or positive endophenotypes (see below), should not be aggregated in prevention or intervention trials unless there is clear evidence for the effectiveness of doing so.
2 Many group treatments constitute high-risk environments that can potentiate genetic risk for psychiatric morbidity and mortality.
Finally, prevention researchers should evaluate the effects of biological risk and Biology Â Environment interactions in predicting longterm treatment outcomes. Such efforts will lead to advances in our understanding of complex disorders, and to refined treatments for subgroups of patients with different etiologies (Cicchetti, 2007 ; see the following).
Genetic vulnerabilities give rise to broad classes of homotypic disorder
Most disorders within the externalizing spectrum share a common heritable vulnerability, as do most disorders within the internalizing spectrum (Baker, Jacobson, Raine, Lozano, & Bezdjian, 2007; Kendler, Prescott, Myers, & Neale, 2003; Krueger et al., 2002 ; see also Krueger & Markon, 2006) . These within-spectrum vulnerabilities give rise to homotypic comorbidity: the co-occurrence of multiple externalizing disorders within an individual or the co-occurrence of multiple internalizing disorders within an individual. For example, ADHD, oppositional defiant disorder (ODD), CD, antisocial personality disorder (ASPD), and SUDs often co-occur (Lewinsohn, Shankman, Gau, & Klein, 2004; Nadder, Rutter, Silberg, Maes, & Leaves, 2002) . Comorbidity of internalizing disorders, including depression, dysthymia, and many anxiety disorders, is also high (Angold & Costello, 1993; Brady & Kendall, 1992; Cloninger, 1990; Donaldson, Klein, Riso, & Schwartz, 1997; Ferdinand, Dieleman, Ormel, & Verhulst, 2007) .
Traditionally, it has been assumed that comorbidity reflects distinct yet co-occurring disorders with different etiologies (see Beauchaine, 2003; . This interpretation is implied by the Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2000), which treats most comorbidity as a differential diagnostic issue. Yet when we assume that different syndromes within the internalizing or externalizing spectra are diagnostically distinct, our approach to science, including prevention and intervention, can become artificially fractionated. This is illustrated in research on externalizing disorders, where largely separate literatures, both basic and applied, have evolved to address different diagnostic syndromes. Researchers and clinicians alike tend to specialize in particular disorders, such as ADHD, CD, or substance use. Even though homotypic comorbidity among these disorders is extremely high (e.g., Beauchaine et al., 2001; Cohen, Chen, Crawford, Brook, & Gordon, 2007; Hinshaw, 1987) , very different treatment approaches have evolved for each. Psychostimulants are the front line treatment for ADHD (MTA Cooperative Group, 1999) , behavioral, and multisystemic interventions are preferred for CD (Brestan & Eyberg, 1998; Nock, 2003) , and motivational techniques are often favored for SUDs, particularly among adolescent users (Masterman & Kelly, 2003; Monti et al., 1999) .
With the exception of ADHD, most treatments for externalizing disorders were developed with little or no attention to biological vulnerabilities. This is understandable, given how little was known about the biological substrates of externalizing risk until quite recently. However, it is now clear that dysfunction in the mesolimbic dopamine (DA) system, including the ventral tegmental area and its projections to the nucleus accumbens, the caudate, and the putamen, is a core neural substrate of risk for all or most externalizing behaviors (Beauchaine & Neuhaus, 2008; Gatzke-Kopp & Beauchaine, 2007a , 2007b Gatzke-Kopp et al., 2007) . Studies using both PET and fMRI indicate that inadequately low levels of DA and associated neural activity in the primary reward centers of the brain predispose to sensation seeking, irritability, negative affectivity, and low motivation, which are core symptoms of externalizing psychopathology Durston, 2003; Laakso et al., 2003; Leyton et al., 2002; Scheres, Milham, Knutson, & Castellanos, 2007; Vaidya et al., 1998) . This central DA dysfunction is a likely endophenotype of genetic risk. As noted above, additive genetic effects account for roughly 80% of the variance in vulnerability to disorders across the externalizing spectrum (Krueger et al., 2002) . Parallel findings apply to internalizing disorders as well (Kendler et al., 2003) . In addition to explaining homotypic comorbidity, central DA dysfunction likely also accounts for homotypic continuity, or the sequential development of different internalizing or externalizing disorders across the life span (see, e.g., Ferdinand et al., 2007) . For example, seriously delinquent adult males are likely to have traversed a developmental pathway that began with hyperactive/impulsive behaviors in toddlerhood, followed by ODD in preschool, early-onset CD in elementary school, SUDs in adolescence, and ASPD in adulthood (see Loeber & Hay, 1997; Loeber & Keenan, 1994; Lynam, 1996 Lynam, , 1998 .
Implications for prevention and intervention.
Depending on when in this developmental progression prevention or intervention is initiated, treatments are likely to be very different, having emerged from distinct intellectual and empirical traditions. As a result, many empirically supported treatments target specific diagnostic syndromes (e.g., SUDs), and are limited in their capacity to address homotypic comorbidities (e.g., ADHD, CD, delinquency; see, e.g., . Yet comorbidity that is mischaracterized may misdirect therapeutic efforts and reduce treatment efficacy. Furthermore, comorbidity can be a critical barrier to the dissemination of evidenced-based treatments, most of which do not address co-occurring disorders (Addis, Wade, & Hatgis, 1999) . Thus, a detailed understanding of biological risk for homotypic comorbidity and continuity has very tangible implications for prevention and intervention. Some of these implications are outlined below.
First, prevention and intervention programs should not focus on single disorders. Individuals who are vulnerable to one internalizing or externalizing disorder are usually vulnerable to others within the same spectrum. Homotypic comorbidity should be expected and addressed explicitly.
In addition, the effects of most prevention programs on distal outcomes will be modest at best. Treated individuals are likely to develop additional externalizing behaviors and/or disorders as they move into different developmental epochs. For example, children treated for ODD in preschool are at risk for serious conduct problems later (see Campbell, Shaw, & Gilliom, 2000) . Similarly, hyperactive boys with conduct problems who undergo pharmacological and/or behavioral treatments early in childhood are not protected from delinquency in later childhood, or from criminality as adults, even when shortterm outcomes are favorable (Molina et al., 2007; Satterfield et al., 2007) . Programs should therefore be designed to anticipate and mitigate homotypic continuity through empirically supported adjunctive treatments and intensive regular follow-ups.
Prevention and intervention programs should also be multifaceted. In the case of externalizing disorders, in addition to being treated for specific diagnostic syndromes such as CD, enrollees should also be taught strategies for coping with impulsivity, because this broad behavioral predisposition confers vulnerability to other externalizing disorders. Similarly, those being treated for specific internalizing disorders should also be taught strategies for coping with trait anxiety (see, e.g., Conrod, Stewart, Comeau, & Maclean, 2006) . In other words, prevention and intervention programs need to address risk for psychopathology across the internalizing or externalizing spectra, even for disorders that are not yet apparent but lie in homotypically continuous pathways. For example, interventions for CD should include substance use prevention modules, even when treated individuals have not yet developed SUDs.
Common genetic and neural effects influence diverse classes of heterotypic disorder
In contrast to comorbidity within the internalizing and externalizing spectra, comorbidity across domains (e.g., depression and CD) is more surprising given that symptoms overlap minimally. This has been referred to as heterotypic comorbidity because internalizing and externalizing disorders are often assumed to be of different origins, whether biological or environmental. Depression includes symptoms of depressed mood, anhedonia, and feelings of guilt or worthlessness, and is usually manifested in a withdrawn behavioral presentation. In contrast, CD is characterized by symptoms such as sensation seeking, lying, property destruction, and aggression. However, despite these different presentations, rates of comorbidity of CD and depression are far greater than expected by chance (e.g., Capaldi, 1991; Drabick, Beauchaine, Gadow, Carlson, & Bromet, 2006) .
A key assumption of most research on heterotypic comorbidity is that identifying which disorder is primary will lead to more effective prevention and intervention programs. Once the primary disorder is identified and treated, secondary disorders are expected to remit. For example, some have argued that among children with CD, comorbid depression follows from the consequences brought about by oppositional, aggressive, and otherwise delinquent behaviors (Capaldi, 1991 (Capaldi, , 1992 Patterson & Capaldi, 1990; Patterson, DeBaryshe, & Ramsey, 1989) . These actions elicit peer rejection, restrict access to resources, promote school failure, and result eventually in institutionalization. Any or all of these consequences may precipitate an endogenous depression that is expected to abate after successful treatment of CD.
Following this reasoning, many researchers have used family history methods to ascertain whether CD or depression is primary in comorbid cases. Yet such family history analyses suggest that neither disorder is primary, and that CD and depression are transmitted across generations separately, through complex biological and environmental mechanisms . This argues against targeting primary disorders to improve treatment efficacy, and implies that both disorders should be treated simultaneously.
Studies of overlapping biological vulnerabilities for CD and depression indicate why heterotypic comorbidity is so common. At the behavioral level, both disorders are characterized by negative affectivity, irritability, and anhedonia. At the neural level, each of these symptoms has been linked with reduced activation in DA-mediated structures involved in approach motivation, regardless of whether CD or depression is the "primary" disorder (Bogdan, & Pizzagalli, 2006 Kopp & Beauchaine, 2007a; Scheres et al., 2007; Vaidya et al., 1998) . Thus, these disorders appear to share a common neural deficiency that accounts for overlap in symptoms. This conclusion is consistent with results from behavioral genetics studies indicating common heritable vulnerability for depression and antisocial behavior (O'Connor, McGuire, Reiss, Hetherington, & Plomin, 1998) .
This deficiency in DA-mediated reward circuitry is moderated by other biologically influenced traits to affect behavior. One such trait is behavioral inhibition (see Figure 2) , which differentiates between those who present principally with CD and those who present principally with depression (Beauchaine, 2001; Beauchaine & Neuhaus, 2008) . In this model, high trait anxiety potentiates depression among those with blunted reward systems, whereas low trait anxiety potentiates delinquency. Trait anxiety is modulated by an entirely different (primarily serotonergic) neural network, often referred to as the septohippocampal system (Gray & McNaughton, 2000) .
Implications for prevention and intervention.
Understanding common and unique mechanisms of internalizing and externalizing psychopathology has several implications for prevention and intervention. As noted above, treatment programs should not focus on single disorders. Individuals who are vulnerable to externalizing T. P. Beauchaine et al. disorders such as CD may also be vulnerable to internalizing disorders such as depression, and vice versa. It should not be assumed that treating one disorder will eliminate the other. Although not as common as homotypic comorbidity, heterotypic comorbidity should be evaluated and addressed explicitly in prevention and intervention programs.
When possible, such programs should also be designed to capitalize on heterotypically comorbid conditions that moderate treatment response. For example, symptoms of anxiety are not uncommon among impulsive children with ADHD and CD (Angold, Costello, & Erkanli, 1999; MTA cooperative group, 1999) . Compared with their nonanxious counterparts, anxious children with ADHD and conduct problems are more responsive to behavioral interventions, and to interventions that include a classroom behavior management component (Beauchaine, Webster-Stratton, & Reid, 2005; Jensen, Hinshaw, Kraemer et al., 2001) . By assessing trait anxiety early in the treatment process, children can be assigned to intervention conditions from which they are most likely to benefit.
In addition, prevention and intervention programs should be designed to mitigate increased risk that is indicated by the presence or absence of heterotypically comorbid conditions . For example, an impulsive child who is low on trait anxiety may be especially vulnerable to developing extremely serious externalizing disorders. Psychopathy, a behavior pattern characterized by manipulation of others, superficial charm, callousness, and lack of remorse, is probably the most intractable form of externalizing conduct (Lykken, 2006) . Psychopaths exhibit excessive approach behaviors that are coupled with a disturbing lack of anxiety and fear (e.g., Fowles & Dindo, 2006) . Because their impulsive tendencies are not inhibited by impending consequences, callous and unemotional males with conduct problems are very resistant to current treatments (e.g., Hawes & Dadds, 2005) . Thus, further refinement of intervention programs for these individuals with these traits is needed.
Individual differences in neurobiologically based traits affect treatment response
Differential treatment responses of externalizing children with and without comorbid anxiety provide one example of a neurobiologically based trait that moderates intervention effects Jensen, Hinshaw, Kraemer et al., 2001) . Preliminary data suggest additional neurobiological moderators for other psychiatric conditions. For example, patterns of both amygdala and subgenual cingulate cortex reactivity to emotional stimuli predict treatment response for those with depression (Siegle, Carter, & Thase, 2006) . Similarly, pilot data indicate that skin conductance reactivity to gambling tasks predicts prevention response to programs aimed at curbing adolescent substance use (Fishbein et al., 2004) . Finally, heart rate variability appears to moderate the effects of treatment for boys with conduct problems and depression (Beauchaine, Gartner, & Hagen, 2000) .
A particularly compelling example comes from the work of Conrod and colleagues (2006) , who have conducted a series of studies indicating that individual differences in biologically based personality traits affect both vulnerability to SUDs and intervention responses. Impulsive and sensation-seeking individuals tend to use substances for their reward properties, whereas those high on trait anxiety tend to use for the anxiolytic effects (Conrod, Pihl, Stewart, & Dongier, 2000) . These individual differences can be detected in part from physiological responses to alcohol Conrod, Peterson, Pihl, & Mankowski, 1997; Conrod, Pihl, & Vassileva, 1998) . For example, men who score high on measures of reward sensitivity and sensation seeking show larger heart rate responses to alcohol than men who score low on such measures (Brunelle et al., 2004) . Among women, those with depressive symptoms of introversion and hopelessness preferentially use substances with analgesic properties (Conrod et al., 2000) .
Implications for prevention and intervention. Until quite recently, most prevention and intervention programs aimed at curbing adolescent risk for SUDs were generic, with the same content applied to everyone . Although outcome data on drug use are sparse, such programs have very limited effects on drinking behaviors ). Findings outlined above specifying different motives for substance use suggest that targeted interventions might improve treatment efficacy. Preliminary research supports this conjecture. Alcohol use interventions with treatment manuals targeting specific personality risk factors (anxiety sensitivity, sensation seeking, and hopelessness) and associated coping strategies yield beneficial effects in terms of abstinence, binge drinking, and drinking quantity. These interventions also yield Personality Â Treatment Condition interactions in predicting outcome, suggesting an important role for targeted interventions in future research and practice . Moreover, such interventions can reduce the impact of comorbid psychological problems (depression, panic attacks, truancy) that are associated with personality risk (Castellanos & Conrod, 2006) .
Although considerable research remains in the development of targeted interventions for SUDs, including additional treatment-outcome studies , these results suggest a clear role for evaluating high-risk traits that predispose to different motives for use. It is important that, even though impulsivity, anxiety sensitivity, and sensation-seeking have clear genetic and neurobiological substrates (see Beauchaine, 2001; Cloninger, Svrakic, & Svrakic, 1997; Corr, 2004; Gray & McNaughton, 2000; Sagvolden et al., 2005) , each can be assessed reliably using self-report measures.
Finally, assessing biological factors that affect treatment response can indicate why some children do not respond to current treatment approaches, information that can be used to develop targeted interventions that are more effective (see Beauchaine et al., 2005; Gunnar & Fisher, 2006) . As noted above, children, adolescents, and adults who exhibit callous unemotional traits and autonomic underarousal benefit little from current interventions for conduct problems and delinquency (see e.g., Fowles & Dindo, 2006; Hawes & Dadds, 2005; Lykken, 2006) . Nevertheless, few prevention or intervention programs target such traits, a disservice to those at highest risk. Nearly a decade ago, Brestan and Eyberg (1998) implored the child psychopathology research community to ask the questions "For whom does this treatment work?" and "When is this treatment not enough?" By identifying characteristics (both biological and psychological) that predict poor treatment response, we begin to address these important questions. To date, very little research aimed at refining prevention and intervention programs to accommodate such individual differences has been conducted.
Biological vulnerabilities moderate the effects of environment on behavior
In addition to their moderating effects on treatment outcome, biologically based vulnerabilities also moderate the effects of broader environmental contexts on behavioral adjustment. For example, respiratory sinus arrhythmia (RSA), a measure of parasympathetic-linked cardiac activity that is roughly 50% heritable (Kupper et al., 2005) , consistently predicts strong emotion regulation capabilities in both children and adults (see Beauchaine, 2001; Beauchaine et al., 2007) , and protects children from developing psychopathology in high-risk environments. In a large study of conduct problems and depression among children and adolescents, high RSA offered partial protection from the development of conduct problems among participants with antisocial fathers . In the same study, high RSA also conferred partial protection from the development of depression among participants of mothers with symptoms of melancholia.
Similarly, children with high RSA who witness marital conflict and hostility or are exposed to problem drinking by their parents are buffered from associated risk of developing both internalizing and externalizing behaviors (El-Sheikh, 2005; El-Sheikh, Harger, & Whitson, 2001; Katz & Gottman, 1995 . Thus, across a wide range of environmental risks, high RSA confers partial protection from psychopathology. According to the nomenclature proposed by Luthar, Cicchetti, and Becker (2000) , these are protective-reactive interactions. Similar results were obtained by Boyce et al. (2006) , who reported that children's autonomic reactivity moderated the effect of father involvement on later mental health outcomes.
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Implications for prevention and intervention. A corollary of these findings is that children with low RSA are particularly vulnerable to developing psychopathology in high-risk environments. In the study of conduct problems and depression cited above, children with low RSA were vulnerable to developing both conduct problems and depression . These findings imply that assessing RSA may help to identify children who are in greatest need of prevention services given familial risk factors including parental antisocial behavior, depression, marital conflict, and problem drinking (see also Beauchaine et al., 2007) .
Similar findings have been reported for other neurobiological systems. For example, Davies, Sturge-Apple, Cicchetti, and Cummings (2007) reported that low cortisol reactivity among kindergarteners in response to parental conflict marked risk for developing externalizing behaviors at 2-year follow-up. This longitudinal relation indicates some degree of prospective risk identification. Early detection of risk is extremely important given the well-documented erosion of treatment effects across development for programs aimed at curbing externalizing behaviors (Dishion & Patterson, 1992; Ruma, Burke, & Thompson, 1996) . The earlier at-risk children are enrolled in prevention programs, the better. Thus, any means of identifying risk prospectively should be embraced by researchers and practitioners (Beauchaine & Marsh, 2006) .
Many null findings for biological (and other) treatment moderators are likely the result of underpowered statistical tests
One argument for questioning the role of biological vulnerabilities as moderators of treatment response and other outcomes is that few such moderators have been identified to date, with several null findings reported (e.g., Coryell & Turner, 1985; Insel & Goodwin, 1983; KleinHessling & Lohaus, 2002; Raine et al., 2003) . 4 An often underappreciated reason for null findings in tests of moderation is that statistical interactions, which specify the moderation effect, have considerably less power than the main effects in a regression or analysis of variance (ANOVA) model (Aiken & West, 1991; Beauchaine & Mead, 2006; Kraemer, Wilson, Fairburn, & Agras, 2002; Whisman & McClelland, 2005) . Although there are several reasons for this, three issues stand out as particularly important. First, the power to detect any effect in statistics depends on the reliability of the measures used. The more measurement error, the lower the statistical power. Unreliabilityiscompoundedwhentestingmoderation effects because the reliability of the interaction term (a Â b) equals the product of the reliabilities of the main effects. Even with high reliabilities for both the independent variables (IV) and the moderator (e.g., .85 each), the reliability of the interaction term is reduced considerably (.85Â.85 ¼ .72). As a result, achieving a conventionally acceptable power level of .80 (a ¼ .05) to detect a medium-sized interaction effect (partial r 2 ¼ .13; see Cohen, 1988 ) requires a 50% increase in participants over that required to detect a medium-sized main effect (r 2 ¼ .24). Thus, many studies with adequate power to detect 3. Although Boyce et al. (2006) suggested that father involvement moderated the effects of autonomic activity on mental health, independent variables (IVs) and moderators are fully interchangeable in statistical tests of interaction. Thus, the mathematics are identical whether father involvement is considered the IV (predictor) and autonomic reactivity is considered the moderator or vice versa. Either way, the effect of one variable (e.g., autonomic activity) differs as a function of the other variable (father involvement) in predicting outcome.
4. In addition, although biological variables have rarely been used to assign participants to different treatment groups, some large scale and highly publicized interventions in which participants were matched to different treatment conditions based on key individual differences have yielded no detectable moderation effects (DiClemente et al., 2001 ; Project MATCH research group, 1997).
main effects do not have sufficient power to detect moderation. Because most researchers conduct power analyses only for main effects, frequent null findings for interaction effects should be expected. Second, many moderating effects in psychological research are ordinal, particularly in treatment-outcome studies. In other words, the slopes of the regression lines for different treatment groups have the same sign at different levels of the moderator. Such is the case when two groups improve during treatment, but one group improves more than the other. Power to detect moderators is considerably less for ordinal interactions than for crossover interactions (see Whisman & McClelland, 2005) .
Third, despite stern warnings from statisticians, many researchers dichotomize variables to test for moderation. It remains a common practice to first divide the putative moderator (often by performing a median split) and then test the correlation between the IV and the dependent variable (DV) in the resulting subgroups, a strategy advanced originally by Baron and Kenny (1986) . Although it is essential to interpret a moderating effect by examining the relation between the IV and DV at different levels of the moderator, this should be done only after a significant effect is found using the continuous product term (aÂb) to compute the interaction. Although there are several compelling reasons to avoid dichotomizing continuous variables (MacCallum, Zhang, Preacher, & Rucker, 2001) , the point here is that doing so results in further erosion of statistical power for effects that are already underpowered given the considerations noted.
Implications for prevention and intervention.
Many studies in which moderators of treatment outcome are tested do not have sufficient power to detect interaction effects. Tests of Biology Â Environment (and any other) interactions are often ancillary to tests of main effects on which power calculations are based. The likely aggregate effect is a literature-wide underestimation of the importance of treatment moderators, including biological vulnerabilities. Indeed, an interaction effect that is considerably larger than a significant main effect may go undetected in the same study. This may be in part responsible for some concluding that biological moderators are irrelevant for prevention and intervention (e.g., Albee & Joffe, 2004) .
Accordingly, prevention and intervention researchers who consider biologically based individual differences as moderators of treatment outcome should calculate the statistical power of interaction effects in advance to ensure that any null findings are not the result of inadequate sample size (Kraemer et al., 2002; Whisman & McClelland, 2005) . As summarized above, ignoring issues of power often leads to erroneous null conclusions (Type II errors). This suggests that many null findings from tests of moderation should be revisited.
Biology Â Environment interactions sometimes explain more variance in outcome than main effects Despite the problems with power noted above, Biology Â Environment interactions sometimes account for considerably more variance in key outcomes than main effects. Yet in the history of clinical science, most research has evaluated the effects of single variables (either biological or environmental) on behavior (see Porges, 2006) . Questions such as "What are the genetic determinants of schizophrenia?" and "How do neighborhood influences promote delinquency?" reflect a predominant focus on main effects. Although such questions are clearly important, evaluating main effects in isolation can obscure equally important interactions between biological vulnerabilities and environmental risk factors in predicting psychopathology. This can lead researchers to conclude that one class of variables (biology or environment) is unrelated to outcome, even when such variables are critical determinants of adjustment.
For example, in our research on self-injury among adolescent girls (see Crowell et al., 2005 Crowell, Beauchaine, & Lenzenweger, 2008) , we reported a significant interaction between participant's peripheral serotonin levels and the quality of dyadic discussions with their mothers in predicting self-harm (e.g., cutting, overdoses, etc.). Adolescent girls with low levels of peripheral serotonin tended toward self-harm regardless of observed dyadic negativity with their mothers. In contrast, girls with high levels T. P. Beauchaine et al. of peripheral serotonin were only at risk when dyadic interactions with their mothers were highly negative. Yet serotonin levels and dyadic negativity were unrelated to one another, and accounted for only 3 and 23% of the variance in self-harm, respectively. However, by adding a Serotonin Â Dyadic Negativity interaction term into the model, we accounted for 64% of the variance in selfharm. In this case, had we measured only peripheral serotonin, we would have concluded that it is unrelated to self-harm. Similarly, had we measured only dyadic negatively, we would have vastly underestimated its importance. As illustrated in Figure 3 , only by assessing the interaction between both variables were we able to explain so much variance in a critically important outcome.
Fortunately, much greater appreciation for interactions between biology and environment has evolved in recent years (see Moffitt et al., 2006; Rutter, 2002 Rutter, , 2007 . Many researchers are now evaluating the combined effects of endogenous and exogenous influences on behavior, which form the crux of both diathesis-stress and moderation models of psychopathology (e.g., Beauchaine et al., 2005; Gottesman & Gould, 2003; Kraemer,Stice,Kazdin, Offord,&Kupfer,2001) . It is now widely recognized that Gene Â Environment and NeurobiologyÂEnvironment interactions are critical in the expression of diverse classes of disorder (Cicchetti, 2007) , including schizophrenia (e.g., Gottesman & Gould, 2003; Lenzenweger, 2006 ) delinquency (e.g., Beauchaine et al., 2007 Caspi et al., 2002; Lynam et al., 2000) , depression (e.g., Caspi et al., 2003) posttraumatic stress disorder (e.g., Orr et al., 2003; Stein, Jang, Taylor, Vernon, & Livesley, 2002) , ADHD (e.g., Seeger, Schloss, Schmidt, Rüter-Jungfleisch, & Henn, 2004) , and SUDs (e.g., Kendler et al., 2003) . This research reveals that for many forms of psychopathology, neither biological vulnerabilities nor high-risk environments are sufficient in isolation to explain etiology; their combined effects must be considered (Beauchaine, Hinshaw, & Gatzke-Kopp, 2008) .
Environments potentiate and mollify biological vulnerabilities through mechanisms of epigenesis, neural plasticity, and pruning Although underappreciated until quite recently, environmental influences shape and maintain biological vulnerabilities for psychopathology in a number of ways. Adverse experiences, particularly trauma and adverse rearing conditions faced early in life, can alter gene expression, with downstream consequences for both central nervous system development and behavior. The term epigenesis refers to changes in gene expression that result from alterations in DNA structure (as opposed to sequence; Hartl & Jones, 2002) . Such alterations are mediated by methylation processes that are triggered by environmental events. For example, Weaver et al. (2004) reported epigenetically transmitted genetic variation in the glucocorticoid receptor gene promoter in the hippocampi of rat pups that experienced high levels of maternal licking, grooming, and arched-back nursing compared with pups that experienced low levels of these rearing behaviors. This epigenetic maternal programming effect transmits adaptive variations in stress responding to offspring (see Meany, 2007) . Rat pups reared in high-risk environments where normal maternal behaviors are compromised have more reactive hypothalamic-pituitary-adrenocortical responses, and are therefore more fearful and wary. Thus, they are better prepared for the high-risk environment that they are likely to face as they continue to develop.
Although clear epigenetic effects among humans have yet to be identified (see Rutter, 2007) , mammals are particularly susceptible to environmentally mediated changes in gene expression (Hartl & Jones, 2002) , and increasingly divergent patterns of DNA methylation emerge over the life spans of monozygotic twins (Fraga et al., 2005) . Accordingly, several authors have noted the potential importance of epigenetic effects for research in child psychopathology (e.g., Kramer, 2005; Rutter, 2005) . However, demonstrating these effects in humans is difficult because it requires random assignment of groups to different environments (e.g., impoverished vs. enriched). Nevertheless, theoretical models of antisocial behavior that include epigenetic effects have been described (Tremblay, 2005) . Moreover, recent studies suggest that brain-derived neurotrophic factor, which is involved in the differentiation of DA neurons in developing mesolimbic structures, may be susceptible to paternally mediated epigenetic effects that confer risk for ADHD and other externalizing behaviors (Kent et al., 2005) .
In contrast to epigenesis, neural plasticity refers to structural and functional brain changes that result from development, experience, and/ or learning. Plasticity has been defined as "permanent functional transformations . . . in particular systems of neurons as a result of appropriate Figure 3 . The main effects of (top) dyadic mother-daughter negativity and (middle) adolescent peripheral serotonin on lifetime self-harm events in a sample of 41 adolescent girls. Negativity and peripheral serotonin accounted for 23 and 3% of the variance in self-harm, respectively. In contrast, (bottom) the conjoint effects of negativity and peripheral serotonin accounted for 64% of the variance in self-injury. From "Parent-Child Interactions, Peripheral Serotonin, and Self-Inflicted Injury in Adolescents," by S. E. Crowell, T. P. stimuli or their combination" (Konorski, 1948) . Mechanisms of plasticity alter the efficiency, activation thresholds, and time course of responding within and across neural systems (see Ciccetti & Blender, 2006; Pollak, 2005) . These transformations include both short-term modulations at neural synapses and long-term changes involving anatomical growth and pruning of neural connections. Pruning refers to the selective elimination of cells and synapses, and may occur as a result of programmed cell death or experience. Presumably, pruning eliminates unused and inefficient connections to improve the overall efficiency and specificity of neurotransmission.
Plasticity, programmed cell death, and pruning are critical mechanisms of neural development (see Perry, 2008) . These processes are widespread prenatally, but continue postnatally, and to a lesser extent, into adulthood. Both heredity and experience impact neural plasticity and pruning, shaping the function of neural systems subserving motivation, emotion, and selfcontrol. An individual's genes create boundaries on developmental trajectories, functioning, and plasticity of neural systems, and provide the bases for later integration of experience (Cicchetti & Curtis, 2006; Hammock & Levitt, 2006) . The impact of experiences on neural and behavioral development is influenced by the timing, duration, and intensity of stimuli, and by biological vulnerabilities, resiliencies, potentiating risk factors, and protective effects (Gunnar & Fisher, 2006; Pollak, 2005) . Hammock and Levitt (2006) describe how the timing of an adverse event is a critical determinant of the brain region affected. For example, postnatal disruptions in maternal infant care in rodents result in delays of synaptic formation in the developing amygdala, cortex, and brain stem, but not in other regions that developed prenatally such as hypothalamic-brain stem connections. Such studies also document how disturbances in early maternal care create long-lasting changes in neural development that persist into the rodent homologues of human adolescence and adulthood (see Gunnar & Fisher, 2006) .
The prenatal period is a critical time of development during which exposure to teratogens can result in structural and functional brain changes and persistent risk for severe psychopathology (see Fryer, Crocker, & Mattson, 2008) . For example, in addition to the well-known effects of in utero ethanol exposure on children's risk for psychiatric disturbance, maternal nicotine exposure during pregnancy is associated with risk for externalizing behaviors among offspring. It is important that significant second-hand exposure may be just as harmful as maternal smoking. In a recent study of 7-to 15-year-olds, children of mothers who did not smoke but reported regular exposure to second-hand smoke during pregnancy, either at home or in the workplace, were at similar risk for impulsivity and conduct problems compared with children whose mothers smoked (Gatzke- Kopp & Beauchaine, 2007b) . In addition to inducing long-term reductions in central DA reactivity (Kane, Fu, Matta, & Sharp, 2004) , nicotine mimics the effects of acetylcholine neurotransmission (Oliff & Gallardo, 1999) , eliciting changes in a number of cellular processes including replication, differentiation, and sensitivity to later stimulation (Slotkin, 1998) . These alterations in both dopaminergic and cholinergic neurotransmission are enduring enough to translate into problems with externalizing psychopathology well into childhood and adolescence.
As noted, neural plasticity effects are not limited to prenatal and perinatal development. Genetic predispositions toward fearfulness may interact with environmental events to alter neural circuits involved in the experience and expression of emotion, thereby amplifying and maintaining anxious behavior throughout the life span (Fox, Hane, & Pine, 2007) .
Implications for prevention and intervention. In addition to these negative effects, neural plasticity and pruning may provide opportunities for resilience and positive adaptation (Cicchetti & Blender, 2006; Cicchetti & Curtis, 2006 Masten, 2007) . Rodent studies of optimal maternal care document changes in gene expression in offspring associated with improved stress resilience (Kaffman & Meaney, 2007) . Among humans, effective psychosocial interventions may result in adaptive changes in brain function well into adulthood. For example, CBT for adult patients with PTSD results in functional brain changes as measured by MRI (Felmingham et al., 2007) . Improvement in PTSD symptoms is associated with increased activity in the anterior cingulate cortex and decreased activity in the amygdala during fear processing. Functional brain changes resulting from psychotherapy have been reported for a host of other disorders as well (e.g., Baxter et al., 1992; Goldapple et al., 2004; Paquette et al., 2003) . These changes are often effected through the same neural pathways that are targeted by pharmacologic interventions (see Kumari, 2006) .
Although some degree of epigenesis and neural plasticity are observed across the life span (e.g., Eriksson et al., 1998) , neural adaptations are more frequent and occur more readily in childhood (see e.g., Perry, 2008) , with certain exceptions for later-maturing brain regions such as the oribitofrontal and prefrontal cortices, areas that exhibit considerable plasticity into adulthood (Sowell et al., 2003) . This general trend of decreasing plasticity across development underscores points outlined above concerning the urgency of initiating prevention and early intervention programs as soon as possible for those at highest risk for psychopathology (Beauchaine & Marsh, 2006) . Because younger brains are more malleable, early intervention provides greater opportunities for (a) conferring protective long-term functional changes in neural systems subserving mood, motivation, and self-regulation; (b) halting the progression of emergent neural vulnerabilities; and (c) reversing existing neural vulnerabilities.
Extensive neural plasticity during prenatal, perinatal, and early childhood development also underscores the need to develop more effective prevention programs targeting young and expectant mothers and their families. Improved prenatal and early childhood care and increased public health awareness are areas where universal prevention programs are potentially most effective. Indeed, nonspecific early educational and healthpromoting interventions for disadvantaged preschoolers confer long-term functional changes in autonomic arousal, and protect enrollees from developing both antisocial and schizotypal behaviors as adults (Raine et al., 2001; Raine et al., 2003) . Expansion and rigorous evaluation of such programs should therefore be a high priority for prevention researchers.
Despite compelling arguments for the earliest interventions possible, we are not suggesting that all is lost for older children and adolescents who experience psychopathology. As noted above, the prefrontal cortex (PFC) maintains considerable plasticity into young adulthood (Sowell et al., 2003) . Given the importance of the PFC in executive functioning, planning, and affect regulation, interventions should be developed that capitalize on skill acquisition in these areas. Indeed, some have suggested that attentional neural networks including the PFC may be modifiable through targeted interventions (see Rueda, Rothbart, Saccomanno, & Posner, 2007) .
Early developing neural systems affect the organization and functioning of later developing neural systems As the discussion above indicates, neural functioning is affected throughout the life span by an individual's developmental history, including both exogenous and endogenous influences. Environmental events affect brain development beginning in utero and extending into adulthood, interacting with genetic predispositions to shape the structure and function of neural pathways subserving behavior regulation. Often these heritable and environmental influences on development are interdependent (see, e.g., Rutter, 2007) . For example, heritable vulnerabilities in earlymaturing neural systems can predispose individuals to behaviors that elicit and/or exacerbate environmental risk. In turn, educed environmental risk can feed back to influence continuing brain development through mechanisms of neural plasticity (see above). Over time, these evocative Biology Â Environment interactions can solidify behavior patterns that were previously malleable.
One behavioral trait that often evokes selfreinforcing effects is impulsivity. Highly impulsive children present with difficult to manage behaviors, which can elicit and strengthen ineffective parenting practices that, in turn, amplify risk for progression to more serious externalizing behaviors Patterson et al., 1989 Patterson et al., , 2000 . As noted above, deficient mesolimbic DA activity is a primary neural substrate of impulsivity and disinhibition (Gatzke- Kopp & Beauchaine, 2007a , 2007b . Deficient mesolimbic DA functioning can result from a number of causes, included heritable vulnerability, prenatal exposure to stimulants, hypoxia, and head injury (Beauchaine & Neuhaus, 2008; Gatzke-Kopp & Shannon, 2008) . In the case of prenatal stimulant exposure, abnormally low mesolimbic DA activity in childhood reflects a lingering neural adaptation to earlier overactivation at the time of exposure (e.g., Kane et al., 2004) . Thus, excessive mesolimbic activation from DA agonists leads to downregulation of a key neural system of behavioral control. In turn, downregulated DA activity predisposes to sensation-seeking behaviors characteristic of conduct problems, criminality, antisocial behavior, and SUDs (Gatzke- Kopp & Beauchaine, 2007a , 2007b ; see also Sagvolden et al., 2005) .
Each of these conditions may further exacerbate neurological vulnerabilities, particularly through early and prolonged exposure to substances of abuse in childhood and adolescence, which induces further changes in DA functioning in mesolimbic structures (e.g., Catlow & Kirstein, 2007) . In this manner, biological vulnerabilities and environmental risk factors reinforce one another, leading to worse outcomes than either factor alone. Similar evocative effects have been described for other high-risk traits, such as anxiety (Fox et al., 2007) .
In addition to cumulative effects within discrete neural systems, evocative cascades that begin in childhood may compromise later developing neural networks, conferring additional vulnerability for heterotypically continuous disorders. The mesolimbic DA system, which develops very early in life, is modulated in adolescence and adulthood by the mesocortical DA system (see Halperin & Schulz, 2006; Spear, 2007) , a frontal neural network that exhibits experience-dependent development into young adulthood (see above). Animal studies identify adolescence as a period of maximum DA activity in the PFC (Tunbridge et al., 2007) , and as a period marked by a DA-dependent shift in the effects of stimulant drugs from dysphorigenic to euphorigenic (Andersen, Leblanc, & Lyss, 2001) .
Children with already compromised yet mature mesolimbic DA systems are placed at even higher risk for psychopathology if neurodevelopment of immature frontal DA systems is also compromised by adverse events. Thus, functional deficiencies in the mesolimbic DA system that give rise to impulsive behaviors and risk for externalizing disorders may be amplified by neuroregulatory processes and evoked environments that compromise experience-dependent neuromaturation of cortical DA networks (see Beauchaine & Neuhaus, 2008) .
Implications for prevention and intervention. The influence of early developing neural systems on later developing neural systems suggests the opportunity for targeted prevention programs. For example, individuals with known prenatal exposure to substances are likely to experience atypical neural development and resulting behavioral and psychological difficulties (Fryer et al., 2008) , marking a clear need for early intervention. Furthermore, regardless of the source, functional deficiencies in key neural systems may confer vulnerability for maladaptive neurodevelopment in latermaturing brain regions, giving rise to additional behavioral difficulties that were not apparent at earlier ages. As already discussed, early dysregulation of the mesolimbic DA system that underlies impulsivity also confers vulnerability for later prefrontal dysfunction, which is associated with deficiencies in complex reasoning, planning, and self-regulation. Early intervention programs should provide protective environments by (a) minimizing exposure to neighborhood risk, delinquent peers, and early initiation of substance use (all of which have been linked with especially poor outcomes for impulsive children), and (b) teaching empirically supported strategies to encourage attentional control and self-regulation (see Rueda et al. 2007) , which may serve to dampen or halt escalating cascades of interdependency among biological vulnerabilities and environmental risks.
It is worth reemphasizing that heterogeneous sources of vulnerability may be important moderators of prevention and intervention outcomes. A single behavioral outcome (e.g., impulsivity) may stem from multiple etiologies across individuals, despite similar behavioral presentations (equifinality). It is possible that impulsivity derived from one source (e.g., brain injury) responds differently to prevention and intervention programs than impulsivity derived from another source (e.g., heritability). For example, although both prenatal ethanol exposure and heritable DA deficiencies give rise to impulsivity, the former condition is typically associated with more widespread neurodevelopmental compromises that are more resistant to current treatment approaches (O'Malley & Nanson, 2002) . For these children, new interventions may be required. Thus, an understanding of the specific vulnerabilities and insults underlying adaptive and maladaptive behaviors within individuals, and an understanding of how resulting behavioral trajectories are likely to unfold over time, are critical to the design, evaluation, and implementation of the next generation of interventions.
Conclusion
Each of the points outlined above underscores the value of adopting an explicit developmental psychopathology approach to prevention and intervention. Almost all forms of psychopathology emerge over the course of development as a result of complex interactions between biological vulnerabilities and environmental risks, neither of which can be ignored in efforts to prevent and treat debilitating psychiatric conditions. Trajectories to psychopathology typically begin very early in development, often expressed initially as heritable vulnerabilities such as impulsivity and trait anxiety. Although insufficient alone to produce severe impairment, these traits interact with high-risk environments (e.g., ineffective parenting, abuse, neglect, neighborhood crime) to potentiate psychopathology in affected individuals. Often cascades of evocative effects begin very early in life, initiating trajectories of maladjustment that become more intractable over time. Accordingly, prevention efforts should be initiated as early in development as possible, and continue throughout childhood and adolescence to prevent the emergence of heterotypically continuous disorders. At the same time, the effectiveness of prevention programs is likely to vary for children with different biological vulnerabilities, even when such vulnerabilities are expressed similarly (equifinality). Thus, children presenting with the same disorders may require different intervention approaches, as demonstrated for those with pure ADHD versus ADHD plus comorbid anxiety (Jensen, Hinshaw, Kraemer, et al., 2001) .
Among the points outlined above, one theme that arises consistently is that considering biological mechanisms in prevention science will increase program efficiency. For some disorders, biological indicators of risk can already identify those most in need of prevention, information that could be used to direct limited resources more effectively. Moreover, understanding biological vulnerabilities that moderate treatment response facilitates more efficient matching of individuals to treatments. As outlined above, this strategy is already yielding important advances in substance abuse interventions for adolescents (e.g., Castellanos & Conrod, 2006; Conrod et al., 2006) . Finally, knowledge of the neurobiological substrates of heterotypic continuity allows us to identify those at especially high risk of life-long impairment, which could facilitate more concentrated and targeted treatment programs.
As discussed, clinical psychology is often slow to respond to paradigm shifts that affect other areas of science much earlier. We have argued that this reluctance slows progress in prevention science, and that efforts to understand biological processes involved in the expression of psychopathology should be embraced. It is our hope that the promise of neuroscience will extend to prevention research and practice in the years ahead, and that more at risk children will benefit as a result.
